公司資料
Akili 股價、新聞與催化劑
- 股票代碼:
- AKLI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for AKLI.
公司概覽
業務概覽
Akili was a digital therapeutics company focused on cognitive treatment and software-based interventions before its public-market decline and restructuring. Its business centered on prescription digital medicine.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Akili sat in digital health.
商業模式特徵
The company depended on product adoption, reimbursement, and the commercialization of software-based therapeutics.
生技產業定位
Akili belongs to the historical digital-therapeutics category rather than the current live public-company set.
未來催化劑
- Akili’s catalysts are now mostly strategic and closeout-related, with any remaining update focused on how the company’s digital-therapeutics assets are being positioned or monetized. The market will care more about corporate clarity than about a fresh product cycle.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。